Successful treatment of advanced esophageal cancer with lymph node metastases by docetaxel, cisplatin and 5-FU followed by salvage lymphadenectomy-A case report

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 12, 2010, Pages 2382-2384

  Takeno, Atsushi ^a   Tamura, Shigeyuki ^a   Miki, Hirofumi ^a   Ono, Hisako ^a   Uchiyama, Chieko ^a   Kanemura, Takeshi ^a   Yanai, Ayako ^a   Kobayashi, Masayoshi ^a   Yoshioka, Yasumasa ^a   Suzuki, Rei ^a   Nakahira, Shin ^a   Nakata, Ken ^a   Okamura, Shu ^a   Takeda, Yutaka ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

And 5 FU (DCF) therapy; Cisplatin; Docetaxel; Esophageal cancer; Salvage lymphadenectomy

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; SALVAGE THERAPY; TREATMENT RESPONSE;

EID: 84866624649     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Kelsen D: Chemotherapy of esophageal cancer. Semin Oncol 11(2): 159-168,1984. (Pubitemid 14088813)
2. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357(17): 1705-1715, 2007. (Pubitemid 350005152)
3. Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. Phase HI study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24 (31): 4991-4997, 2006. (Pubitemid 46631401)
4. Baba H, Nagai Y, Iwagami S, et al. Efficacy and safety of induction chemotharapy with docetaxelJcisplatinJ5-FU for patients with node-positive esophageal cancer. Gastrointestinal Cancers Symposium: abstr 86,2010.
5. Iwaya T, Kimura Y, Noda Y, et al. Evaluation of primary chemotherapy with docetaxel, cisplatin, and fluorouracil for advanced esophageal squamous cell carcinoma. Gastrointestinal Cancers Symposium: abstr 117, 2010.
6. Ura T, Nagase M, Fujii H, et al. Feasibility study of preoperative docetacel (D), cisplatin (C), and fluorouracil (F) in esophageal cancer. Gastrointestinal Cancers Symposium: abstr 81, 2010.
7. Peng Y, Imano M, Imamoto H, et al. Phase II study of docetaxel, cisplatin, and fluorouracil for metastatic esophageal cancer. Gastrointestinal Cancers Symposium: abstr 119, 2010.
8. Ohtsu A: Chemoradiotherapy for esophageal cancer: current status and perspectives. Int J Clin Oncol 9 (6): 444-450. 2004.
9. Doki Y, Yasuda T, Miyata H, et al. Salvage lymphade-nectomy of the right recurrent nerve node with tracheal involvement after definitive chemoradiation therapy for esophageal squamous cell carcinoma: report of two cases. Surg Today 37 (7): 590-595, 2007. (Pubitemid 46998941)